Sign In
Buy PAYS
$6.81
-0.590 (-7.97%)
At Close: Jun 03, 2026
Paysign, Inc. (PAYS) Q4 2024 Earnings Call Transcript
06:27pm, Tuesday, 25'th Mar 2025
Paysign, Inc. (NASDAQ:PAYS ) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President, Patient Afforda
Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results
04:03pm, Tuesday, 25'th Mar 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results.
Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer
08:05am, Tuesday, 25'th Mar 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today
Paysign to Host Fourth Quarter and Full Year 2024 Earnings Call
04:30pm, Thursday, 27'th Feb 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Fourth Quarter and Full Year 2024 Earnings Call.
Paysign: Shifting Revenue Mix, Falling Stock, Compelling Opportunity
03:05am, Wednesday, 19'th Feb 2025
Paysign, Inc. is a small healthcare-focused Fintech company excelling in the $500M Patient Affordability market, with 230% revenue growth in its Pharma segment over the past four quarters. Despite a 4
Paysign Announces 2024 Performance Analysis of Patient Affordability Solutions
08:05am, Tuesday, 04'th Feb 2025
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign Announces 2024 Performance Analysis of Patient Affordability Solutions.
Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth
05:29am, Wednesday, 20'th Nov 2024
Paysign is a promising microcap payment processing company with a projected 42% annualized return, potentially reaching $19/share by 2030 from $3.30/share today. The company excels in two primary sect
Paysign, Inc. (PAYS) Q3 2024 Earnings Call Transcript
09:02pm, Tuesday, 05'th Nov 2024
Paysign, Inc. (NASDAQ:PAYS ) Q3 2024 Earnings Conference Call November 5, 2024 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President, Patient Affor
Paysign, Inc. Reports Third Quarter 2024 Financial Results
04:02pm, Tuesday, 05'th Nov 2024
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated paym
Paysign to Host Third Quarter 2024 Earnings Call
04:30pm, Tuesday, 15'th Oct 2024
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2024 Earnings Call.
Is Paysign (PAYS) Stock Undervalued Right Now?
10:45am, Tuesday, 01'st Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Is Paysign (PAYS) Stock Outpacing Its Business Services Peers This Year?
10:46am, Tuesday, 17'th Sep 2024
Here is how Paysign, Inc. (PAYS) and Recruit Holdings Co., Ltd. (RCRRF) have performed compared to their sector so far this year.
Is Paysign (PAYS) Outperforming Other Business Services Stocks This Year?
10:41am, Thursday, 29'th Aug 2024
Here is how Paysign, Inc. (PAYS) and Recruit Holdings Co., Ltd. (RCRRF) have performed compared to their sector so far this year.
Paysign: The Return Of The King Of Medical Fintech
04:52pm, Monday, 19'th Aug 2024
Niche Focus: Paysign specializes in healthcare payment solutions, primarily in plasma donor compensation and patient affordability programs. Revenue Growth: Significant growth in the patient affordabi
Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference
04:15pm, Thursday, 08'th Aug 2024
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference.
